Pakistan’s pharmaceutical industry has set an ambitious target of achieving USD 10 billion in exports.
The development came during a meeting between Federal Minister for Finance and Revenue, Senator Muhammad Aurangzeb, and a high-level delegation of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) led by Chairman Dr. Tahir Azam.
The PPMA unveiled its vision for “PharmEx Pakistan,” a dedicated export promotion platform designed to bring together public and private stakeholders to accelerate sectoral growth and expand international market access.
Senator Aurangzeb praised the industry’s record 34 percent year-on-year export growth and noted that domestic pharmaceutical production has grown by 18 percent, significantly outpacing the global average of 5 percent. He also highlighted the government’s recent regulatory reforms, which have cut product registration timelines from years to weeks, enabling faster market entry for new drugs.
The meeting concluded with a shared commitment between the government and industry to strengthen collaboration, attract investment, and drive export-led growth in Pakistan’s rapidly expanding pharmaceutical sector.
About the Author
Written by the expert legal team at Javid Law Associates. Our team specializes in corporate law, tax compliance, and business registration services across Pakistan.
Verified Professional
25+ Years Experience